10x Genomics (NASDAQ:TXG) Price Target Cut to $12.00 by Analysts at UBS Group
10x Genomics (NASDAQ:TXG – Get Free Report) had its price objective cut by equities researchers at UBS Group from $14.00 to $12.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s target price indicates a potential upside of 31.58% from the company’s current price. Several […]
10x Genomics (NASDAQ:TXG – Get Free Report) had its price objective cut by equities researchers at UBS Group from $14.00 to $12.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s target price indicates a potential upside of 31.58% from the company’s current price. Several […]
